These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37037907)

  • 1. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
    Ma J; Zhou W; Yuan Y; Wang B; Meng X
    Cancer Gene Ther; 2023 Aug; 30(8):1072-1083. PubMed ID: 37037907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
    Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
    Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
    Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
    Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes.
    Du X; Shen X; Dai L; Bi F; Zhang H; Lu C
    Biochem Biophys Res Commun; 2020 May; 526(2):368-374. PubMed ID: 32222279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
    Zhang H; Li C; Liao S; Tu Y; Sun S; Yao F; Li Z; Wang Z
    Cancer Biol Ther; 2022 Dec; 23(1):1-11. PubMed ID: 36137220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
    Wang H; Chen H; Zhou H; Yu W; Lu Z
    Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway.
    Lv J; Ma S; Wang X; Dang J; Ma F
    Genes Genomics; 2024 Mar; 46(3):263-277. PubMed ID: 38243044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMD12 promotes glioma progression by upregulating the expression of Nrf2.
    Wang Z; Li Z; Xu H; Liao Y; Sun C; Chen Y; Sheng M; Lan Q; Wang Z
    Ann Transl Med; 2021 Apr; 9(8):700. PubMed ID: 33987398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
    Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
    Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.
    Hui X; Cao L; Xu T; Zhao L; Huang K; Zou Z; Ren P; Mao H; Yang Y; Gao S; Sun X; Lin X; Jin M
    J Virol; 2022 Aug; 96(15):e0078622. PubMed ID: 35861516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
    Li WH; Zhang L; Wu YH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.
    Chen Q; Chen K; Guo G; Li F; Chen C; Wang S; Nalepa G; Huang S; Chen JL
    PLoS One; 2014; 9(10):e111611. PubMed ID: 25360622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF8 knockdown triggered growth inhibition and induced cell phase arrest in human pancreatic cancer cells.
    Yi X; Li Y; Zai H; Long X; Li W
    Gene; 2016 Jul; 585(1):22-27. PubMed ID: 26995652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CDKN3 in cervical cancer.
    Berumen J; Espinosa AM; Medina I
    Expert Opin Ther Targets; 2014 Oct; 18(10):1149-62. PubMed ID: 25152075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
    Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
    Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
    Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.